文献速递新生儿儿童感染儿童消化与营养

早产儿早期抗菌药应用对肠道菌群的影响

[Impact on the intestinal microbiota of early antibiotic treatment in preterm neonates].
PubMed 文献 · Zhonghua Er Ke Za Zhi · 2018-01-01

该前瞻性队列研究纳入33例早产儿,比较抗菌药暴露组(25例)与非暴露组(8例)生后第1、14、30天及暴露组生后8个月至1年的肠道菌群。结果显示早期联合抗菌药显著降低肠道菌群丰度和多样性,并减少埃希菌、克雷伯菌、梭菌及双歧杆菌等菌属含量。

要点

  • 早产儿生后肠道菌群以变形杆菌为主,抗菌药暴露组丰度和多样性降低。
  • 生后第30天暴露组shannon指数2.6低于非暴露组3.4,ACE指数563.9低于591.6。
  • 联合抗菌药较单用青霉素对菌群多样性影响更大,双歧杆菌含量更低。

核心结论

  • 早产儿生后早期联合应用抗菌药对肠道菌群影响显著,可降低双歧杆菌、乳酸杆菌、拟杆菌及梭菌含量。

研究设计与样本

  • 前瞻性队列研究,2015年1至6月北京大学第三医院新生儿重症监护病房33例早产儿,抗菌药暴露组25例、非暴露组8例,采集生后第1、14、30天及暴露组生后8个月至1年粪便,高通量测序分析菌群。

主要发现

  • 所有早产儿生后肠道菌群以变形杆菌为主,暴露组69.6%、非暴露组83.7%。
  • 暴露组生后前30天以变形杆菌为优势菌,之后厚壁菌成为优势菌;属水平生后30天内以埃希菌为主,生后8个月至1年韦荣球菌成为优势菌。
  • 非暴露组生后30天内变形杆菌含量最高,属水平生后以不动杆菌37.5%为优势菌,生后30天内以埃希菌为优势菌。
  • 暴露组肠道菌群丰度和多样性减低,生后第30天更明显(shannon指数2.6比3.4,ACE指数563.9比591.6)。
  • 生后第14天暴露组埃希菌(9.3%比54.3%,Z=-2.830,P=0.005)、克雷伯菌(0.03%比12.4%,Z=-2.240,P=0.025)及梭菌(0.2%比4.8%,Z=-2.979,P=0.003)明显低于非暴露组。

关键数值与推荐

  • 联合应用抗菌药组较单用青霉素组对菌群多样性影响更大(shannon指数2.5比2.7,ACE指数492.9比727.3)。
  • 生后第30天联合应用抗菌药组双歧杆菌含量低于单用青霉素组(0.1%比2.0%,Z=-2.349,P=0.019)。

临床怎么用

  • 早产儿生后应谨慎评估早期抗菌药尤其是联合用药的必要性,以减少对肠道菌群丰度和多样性的不利影响。

局限性

  • 研究为单中心小样本队列,非暴露组仅8例,抗菌药暴露组25例,组间比较需谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the impact of early antibiotics treatment on intestinal microbiota in preterm infants. Methods: The cohort study was performed from January 2015 to June 2015 in Neonatal Intensive Care Unit of Peking University Third Hospital. A total of 33 preterm infants were enrolled, among whom 25 were antibiotics-exposure group, and 8 were non-exposure group. Serial stool samples were collected on the first day, 14th and 30th days of life and analyzed by high-throughput sequencing. In exposure group, intestinal microbiota was also analyzed at 8 months to 1 year of age. Categorical variables were analyzed with χ(2) test, and continuous variables were analyzed with t test or non-parametric test. Results:Proteobacteria was the most prominent flora after birth in all cases (exposure group 69.6%, non-exposure group 83.7%) . In exposure group, at the phylum level, Proteobacteria was the dominant bacteria within the first 30 days, followed by Firmicutes after 30 days of life. At the genus level, Escherichia was the most abundant genera within 30 days after birth, while Veillonella became dominant after 8 months to 1 year of life. In non-exposure group, at the phylum level, Proteobacteria was the dominant phylum within the first 30 days. At the genus level, Actinobacteria (37.5%) was the dominant genus after birth, followed by Escherichia within the first month. Intestinal bacterial abundance and diversity were lower in exposure group, which was most significant on 30th day of life (shannon index 2.6 vs.3.4, ACE index 563.9 vs.591.6) . The influence of single antibiotics was less significant than combined treatment (shannon index 2.7 vs.2.5, ACE index 727.3 vs.492.9) . At the genus level, compared to non-exposure group, there were significant decrease of Escherichia (9.3% vs. 54.3%, Z=-2.830, P=0.005), Klebsiella (0.03% vs.12.4%,Z=-2.240, P=0.025), and Clostridium (0.2% vs. 4.8%, Z=-2.979, P=0.003) in exposure group on 14 days of life. Bifidobacterium (0.1% vs.2.0%, Z=-2.349, P=0.019) in cases treated with combined antibiotics was lower than that treated with antibiotic monotherapy on 30 days of life. Conclusions: Early application of combined antibiotics impacts on the intestinal microbiome of preterm infants significantly. The infants who have received antibiotic after birth have lower quantity and diversity of Clostridium, Lactobacillus, Bacteroides and Bifidobacterium. 目的: 探讨生后早期抗菌药应用对早产儿肠道菌群的影响。 方法: 前瞻性队列研究。收集2015年1至6月在北京大学第三医院新生儿重症监护病房住院的33例早产儿的粪便进行临床研究,按是否应用抗菌药分为抗菌药暴露组(25例)及非暴露组(8例),每例患儿分别采集3次粪便:生后第1天、第14天、第30天,抗菌药暴露组同时收集生后8个月~1年随访时的粪便,应用高通量测序对粪便菌群进行分析。计数资料组间比较应用χ(2)检验,计量资料组间比较应用t检验或非参数检验。 结果: 33例早产儿生后肠道菌群主要以变形杆菌为主(抗菌药暴露组69.6%,非暴露组83.7%)。抗菌药暴露组,在门水平,生后前30 d以变形杆菌为优势菌,之后厚壁菌成为优势菌。在属水平,生后30 d内以埃希菌为主要菌群,生后8个月~1年韦荣球菌成为优势菌。非暴露组,在门水平,生后30 d内,变形杆菌含量最高。在属水平,生后以不动杆菌(37.5%)为优势菌,生后30 d内以埃希菌为优势菌。抗菌药暴露组肠道菌群的丰度和多样性减低,生后第30天更明显(shannon指数2.6比3.4,ACE丰度指数563.9比591.6),联合应用抗菌药组比单用青霉素对菌群多样性影响更大(shannon指数2.5比2.7,ACE丰度指数492.9比727.3)。属水平,抗菌药暴露组生后第14天埃希菌(9.3%比54.3%,Z=-2.830,P=0.005)、克雷伯菌(0.03%比12.4%,Z=-2.240,P=0.025)及梭菌(0.2%比4.8%,Z=-2.979,P=0.003)明显低于非暴露组,差异均有统计学意义。生后第30天,联合应用抗菌药双歧杆菌含量低于单用青霉素组,差异有统计学意义(0.1%比2%,Z=-2.349,P=0.019)。 结论: 早产儿生后联合应用抗菌药组较单用青霉素对菌群影响大,应用抗菌药可使双歧杆菌、乳酸杆菌、拟杆菌及梭菌含量减低。.

来源:Zhonghua Er Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Zhu WW, Li ZL. [Impact on the intestinal microbiota of early antibiotic treatment in preterm neonates]. Zhonghua Er Ke Za Zhi. 2018. PMID: 29996183. doi:10.3760/cma.j.issn.0578-1310.2018.07.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。